Multidrug-resistant tuberculosis (MDR-TB) is defined by bacillary resistant to at least isoniazid and rifampicin in vitro. Although a great diversity of reasons accounting for MDR-TB, poor treatment adherence of patient or inappropriate prescription of physicians are still the major causes. Implementation of DOTS (directly observed therapy, short-course) could decrease incidence of MDR-TB. For MDR-TB, prevention is best strategy. Besides, implantation of DOTS-plus also could increase cure rate. To build efficacious framework system for managing tuberculosis is an important issue to prevent and treat MDR-TB.
|Translated title of the contribution||Multidrug-Resistant Tuberculosis|
|Original language||Chinese (Traditional)|
|Number of pages||8|
|Journal||Journal of Internal Medicine of Taiwan|
|Publication status||Published - 2009|
- Multidrug-resistant tuberculosis
- Directly observed therapy, short-course